Danxin Wang1,2, Katherine Hartmann1, Michal Seweryn3, Wolfgang Sadee1. 1. Department of Cancer Biology and Genetics, Center for Pharmacogenomics, College of Medicine, Ohio State University, Columbus (D.W., K.H., W.S.). 2. Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville (D.W.). 3. Center for Medical Genomics OMICRON, UJ CM, Krakow, Poland (M.S.).
Abstract
BACKGROUND: CYP7A1 (cholesterol 7α-hydroxylase) catalyzes the rate-limiting step in bile acid biosynthesis from cholesterol-a main pathway for cholesterol removal from the body. CYP7A1 single-nucleotide polymorphisms (SNPs) are associated with total cholesterol and LDL (low-density lipoprotein) levels, risk of cardiovascular diseases, and other phenotypes; however, results are inconsistent, and causative variants remain uncertain, except for a frequent promoter SNP (rs3808607). METHODS: We used chromatin conformation capture (4C assay), chromatin immunoprecipitation qPCR assay in hepatocytes, and CRISPR (clustered regularly interspaced short palindromic repeats)-mediated genome editing in hepatocellular carcinoma cell line cells to identify regulatory regions for CYP7A1. We then screened for SNPs located in regulatory regions, testing effects on reporter gene assays and on hepatic CYP7A1 expression by measuring allelic mRNA expression imbalance. RESULTS: 4C assays showed several regions interacting with CYP7A1 promoter. CRISPR-mediated genome editing in hepatocellular carcinoma cell line cells revealed a novel CYP7A1 enhancer and a repressor region, located >10 kb downstream of the CYP7A1 promoter. SNP screening with an allelic mRNA expression imbalance in human livers and reporter gene assays identified a frequent functional SNP (rs9297994) located in the downstream CYP7A1 enhancer region. SNP rs9297994 is in high linkage disequilibrium with promoter SNP rs3808607 but has opposite effects on CYP7A1 mRNA expression. Their combined effects using a 2-SNP model robustly associate with hepatic CYP7A1 mRNA expression, ranging >2 orders of magnitude. Moreover, only the 2-SNP model, but not each SNP alone, is significantly associated with LDL levels, risk of coronary artery disease, statin response, and diabetes mellitus in several clinical cohorts, including CATHGEN (Catheterization Genetics) and Framingham. CONCLUSIONS: Two interacting regulatory SNPs modulate CYP7A1 expression and are associated with risk of coronary artery disease and diabetes mellitus.
BACKGROUND:CYP7A1 (cholesterol 7α-hydroxylase) catalyzes the rate-limiting step in bile acid biosynthesis from cholesterol-a main pathway for cholesterol removal from the body. CYP7A1 single-nucleotide polymorphisms (SNPs) are associated with total cholesterol and LDL (low-density lipoprotein) levels, risk of cardiovascular diseases, and other phenotypes; however, results are inconsistent, and causative variants remain uncertain, except for a frequent promoter SNP (rs3808607). METHODS: We used chromatin conformation capture (4C assay), chromatin immunoprecipitation qPCR assay in hepatocytes, and CRISPR (clustered regularly interspaced short palindromic repeats)-mediated genome editing in hepatocellular carcinoma cell line cells to identify regulatory regions for CYP7A1. We then screened for SNPs located in regulatory regions, testing effects on reporter gene assays and on hepatic CYP7A1 expression by measuring allelic mRNA expression imbalance. RESULTS: 4C assays showed several regions interacting with CYP7A1 promoter. CRISPR-mediated genome editing in hepatocellular carcinoma cell line cells revealed a novel CYP7A1 enhancer and a repressor region, located >10 kb downstream of the CYP7A1 promoter. SNP screening with an allelic mRNA expression imbalance in human livers and reporter gene assays identified a frequent functional SNP (rs9297994) located in the downstream CYP7A1 enhancer region. SNP rs9297994 is in high linkage disequilibrium with promoter SNP rs3808607 but has opposite effects on CYP7A1 mRNA expression. Their combined effects using a 2-SNP model robustly associate with hepatic CYP7A1 mRNA expression, ranging >2 orders of magnitude. Moreover, only the 2-SNP model, but not each SNP alone, is significantly associated with LDL levels, risk of coronary artery disease, statin response, and diabetes mellitus in several clinical cohorts, including CATHGEN (Catheterization Genetics) and Framingham. CONCLUSIONS: Two interacting regulatory SNPs modulate CYP7A1 expression and are associated with risk of coronary artery disease and diabetes mellitus.
Authors: Irene V Lambrinoudaki; George I Kaparos; Sofia A Vlachou; Kimon S Stamatelopoulos; George A Georgiopoulos; Thodoris N Sergentanis; Constantinos P Panoulis; George E Christodoulakos; Andreas P Alexandrou; Evangelia E Kouskouni; Maria G Creatsa; Christos M Papamichael Journal: Menopause Date: 2008 Nov-Dec Impact factor: 2.953
Authors: L R Smith; F E Harrell; J S Rankin; R M Califf; D B Pryor; L H Muhlbaier; K L Lee; D B Mark; R H Jones; H N Oldham Journal: Circulation Date: 1991-11 Impact factor: 29.690
Authors: Amit D Joshi; Charlotte Andersson; Stephan Buch; Stefan Stender; Raymond Noordam; Lu-Chen Weng; Peter E Weeke; Paul L Auer; Bernhard Boehm; Constance Chen; Hyon Choi; Gary Curhan; Joshua C Denny; Immaculata De Vivo; John D Eicher; David Ellinghaus; Aaron R Folsom; Charles Fuchs; Manish Gala; Jeffrey Haessler; Albert Hofman; Frank Hu; David J Hunter; Harry L A Janssen; Jae H Kang; Charles Kooperberg; Peter Kraft; Wolfgang Kratzer; Wolfgang Lieb; Pamela L Lutsey; Sarwa Darwish Murad; Børge G Nordestgaard; Louis R Pasquale; Alex P Reiner; Paul M Ridker; Eric Rimm; Lynda M Rose; Christian M Shaffer; Clemens Schafmayer; Rulla M Tamimi; André G Uitterlinden; Uwe Völker; Henry Völzke; Yoshiyuki Wakabayashi; Janey L Wiggs; Jun Zhu; Dan M Roden; Bruno H Stricker; Weihong Tang; Alexander Teumer; Jochen Hampe; Anne Tybjærg-Hansen; Daniel I Chasman; Andrew T Chan; Andrew D Johnson Journal: Gastroenterology Date: 2016-04-16 Impact factor: 22.682
Authors: Adebowale Adeyemo; Amy R Bentley; Katherine G Meilleur; Ayo P Doumatey; Guanjie Chen; Jie Zhou; Daniel Shriner; Hanxia Huang; Alan Herbert; Norman P Gerry; Michael F Christman; Charles N Rotimi Journal: BMC Med Genet Date: 2012-09-21 Impact factor: 2.103
Authors: Siddharth Kishore; Elisa De Franco; Fabian L Cardenas-Diaz; Lisa R Letourneau-Freiberg; May Sanyoura; Catherine Osorio-Quintero; Deborah L French; Siri Atma W Greeley; Andrew T Hattersley; Paul Gadue Journal: Cell Stem Cell Date: 2020-05-21 Impact factor: 24.633
Authors: Peter H Dixon; Adam P Levine; Inês Cebola; Daniel P Gale; Catherine Williamson; Melanie M Y Chan; Aliya S Amin; Anshul Aich; Monika Mozere; Hannah Maude; Alice L Mitchell; Jun Zhang; Jenny Chambers; Argyro Syngelaki; Jennifer Donnelly; Sharon Cooley; Michael Geary; Kypros Nicolaides; Malin Thorsell; William M Hague; Maria Cecilia Estiu; Hanns-Ulrich Marschall Journal: Nat Commun Date: 2022-08-17 Impact factor: 17.694